- Home
- BBCP vs ARCT Comparison
BBCP vs ARCT Comparison
Compare BBCP & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBCP
- ARCT
- Stock Information
- Founded
- BBCP 1983
- ARCT 2013
- Country
- BBCP United States
- ARCT United States
- Employees
- BBCP N/A
- ARCT N/A
- Industry
- BBCP Engineering & Construction
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- BBCP Consumer Discretionary
- ARCT Health Care
- Exchange
- BBCP Nasdaq
- ARCT Nasdaq
- Market Cap
- BBCP 370.5M
- ARCT 444.5M
- IPO Year
- BBCP 2017
- ARCT N/A
- Fundamental
- Price
- BBCP $6.65
- ARCT $17.77
- Analyst Decision
- BBCP Buy
- ARCT Strong Buy
- Analyst Count
- BBCP 4
- ARCT 7
- Target Price
- BBCP $7.67
- ARCT $63.60
- AVG Volume (30 Days)
- BBCP 209.9K
- ARCT 439.9K
- Earning Date
- BBCP 03-06-2025
- ARCT 03-06-2025
- Dividend Yield
- BBCP N/A
- ARCT N/A
- EPS Growth
- BBCP N/A
- ARCT N/A
- EPS
- BBCP 0.26
- ARCT N/A
- Revenue
- BBCP $425,872,000.00
- ARCT $160,399,000.00
- Revenue This Year
- BBCP $1.64
- ARCT $6.54
- Revenue Next Year
- BBCP $5.84
- ARCT $0.25
- P/E Ratio
- BBCP $25.19
- ARCT N/A
- Revenue Growth
- BBCP N/A
- ARCT N/A
- 52 Week Low
- BBCP $5.05
- ARCT $14.30
- 52 Week High
- BBCP $9.68
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- BBCP 29.94
- ARCT 54.71
- Support Level
- BBCP $7.03
- ARCT $16.54
- Resistance Level
- BBCP $8.05
- ARCT $19.25
- Average True Range (ATR)
- BBCP 0.32
- ARCT 1.19
- MACD
- BBCP -0.16
- ARCT 0.14
- Stochastic Oscillator
- BBCP 1.02
- ARCT 62.15
About BBCP Concrete Pumping Holdings Inc.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.